Trial
NCT02221037
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Lung Injury, Acute and Respiratory Distress Syndrome, Adult
Intervention
GSK2862277
Why stopped
The study was terminated on the basis that protocol defined stopping criteria had been met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-27